semaglutide patent expiry in india Rs 10,000-crore opportunity: Sun Pharma, Lupin, Torrent to lead 2026 weight-loss market as Ozempic expires - Industry News India's Semaglutide Patent Expiry Sparks

who can benefit from Neuro Optimizer

The FDA has issued warnings concerning the potential hazards of using unapproved GLP-1 drugs for weight reduction

Is GHK-Cu safe for all skin types

They discuss the day-to-day reality of their journey

For outsourcing facilities under section 503B of the FD&C Act: compounding, distributing or dispensing semaglutide injection products that are essentially a copy of an FDA-approved drug product within 90 calendar days from the announcement, until May 22, 2025.

SURMOUNT-1 trial suggests that tirzepatide may have a promising future as a therapy for obesity, HF, and non-alcoholic fatty liver disease (NAFLD) [5, 8]